drugset / Trial / NCT06879041
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
Non-randomizedSequentialOpen-labelTreatment
Summary
The main purpose of the study is to assess the safety and tolerability of AZD2284, AZD2287, and AZD2275.
Timeline
- Start
- 2025-03-10
- Primary completion
- 2029-04-16
- Completion
- 2029-04-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD2275 | Unknown | — | — |
| Subject | AZD2284 | Unknown | — | — |
| Subject | AZD2287 | Diagnostic / imaging agent | — | — |